SMTL ID : 7u9f.2 (1 other biounit)

Integrin alpha IIB beta3 complex with BMS compound 4 in Mn2+

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.70 Å
Oligo State
hetero-1-1-1-1-mer
Ligands
1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
4 x SO4: SULFATE ION(Non-functional Binders)
2 x CL: CHLORIDE ION(Non-functional Binders)
4 x CA: CALCIUM ION(Non-covalent)
3 x MN: MANGANESE (II) ION(Non-covalent)
1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x I7R: (4-{[(5S)-3-{4-[(E)-imino(4-methylpiperazin-1-yl)methyl]phenyl}-4,5-dihydro-1,2-oxazol-5-yl]methyl}piperazin-1-yl)acetic acid(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Lin, F.Y. et al., A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell (2022)
Release Date
2022-08-17
Peptides
Integrin alpha-IIb: A
Integrin beta-3: B
Fab heavy chain: C
Fab light chain: D
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
C
B
D
C
E
D
F

Integrin alpha-IIb

Integrin beta-3

Fab heavy chain

Fab light chain

Related Entries With Identical Sequence

2vc2.1 | 2vdk.1 | 2vdl.1 | 2vdm.1 | 2vdn.1 | 2vdo.1 | 2vdp.1 | 2vdq.1 | 2vdr.1 | 3nid.1 | 3nid.2 | 3nif.1 | 3nif.2 | 3nig.1 | 3nig.2 | 3t3m.1 | 3t3m.2 | 3t3p.1 | 3t3p.2 | 3zdx.1 | 3zdx.2 | 3zdy.1 | 3zdy.2 | 3zdz.1 | 3zdz.2 | 3ze0.1 | 3ze0.2 | 3ze1.1 | 3ze1.2 | 3ze2.1  more...